Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sodium-glucose Transporter 2 Inhibitor Use in Pre-diabetes: Initial Evaluation in Veterans

NCT06828731 is registered in ClinicalTrials.gov with Charles George VA Medical Center as lead sponsor.

NCT NCT06828731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06828731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sodium-glucose Transporter 2 Inhibitor Use in Pre-diabetes: Initial Evaluation in Veterans
Lead sponsor
Charles George VA Medical Center
Phase
Phase 1
Overall status
Completed
Start date
December 6, 2024
Completion date
September 5, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prediabetes